Updated on 3 May 2012
The order is subject to certain conditions, such as maintaining account of sales and payment of royalty to Bayer at six percent of the net sales on a quarterly basis. The order also makes it obligatory for NATCO to supply the drug free-of-cost to at least 600 needy and deserving patients per year.
NATCO welcomed this order and said this opened up a new avenue for availability of life-saving drugs at an affordable price to the suffering masses in India.
Get direct access to more such reports. Subscribe to BioSpectrum Bureau 
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
